The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.00
Bid: 322.50
Ask: 323.50
Change: -4.50 (-1.38%)
Spread: 1.00 (0.31%)
Open: 326.50
High: 326.50
Low: 322.00
Prev. Close: 326.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Trading and Cyber Security Incident

7 Feb 2023 07:00

RNS Number : 0905P
Morgan Advanced Materials PLC
07 February 2023
 

Press Release

Morgan Advanced Materials plc

7 February 2023

 

Update on Trading and Cyber Security Incident

Morgan Advanced Materials plc (the "Group") provides an update on trading results for 2022 and on the cyber security incident previously announced on 10 January 2023.

Key points

- FY2022 trading performance expected to be slightly ahead of market expectations

- In response to the cyber security incident:

o All manufacturing sites are operational

o Resolution of systems issues continues at pace

o H1 2023 demand remains strong, but production inefficiencies expected to impact FY2023 adjusted operating profit by 10% to 15%

o FY2022 preliminary results now expected to be announced by end of April 2023

Trading Update

Revenue growth remained robust in the final two months of the year with revenue expected to be around £1.1bn, representing growth of 16% or 11% at constant currency. FY2022 adjusted operating profit is expected to be slightly above the top-end of the range of analysts' forecasts¹. Net debt at the year end was £148.6m, in line with market expectations and 0.8x EBITDA.

Cyber Security Incident

As announced on 10 January 2023, the Company is managing the consequences of a cyber security incident having detected unauthorised activity on its network. Immediate steps were taken to contain the incident, launch incident response plans, engage specialist support services and embark on restoring systems.

All manufacturing sites are operational, although some continue to use manual transaction processes as work continues to restore their systems. A small number of systems have proven irrecoverable and so we are accelerating the implementation of a new cloud-based ERP solution at the affected sites. 

All appropriate regulatory authorities have been informed of the incident.

Exceptional costs associated with the incident could amount to approximately £8m to £12m, comprising specialist professional fees, as well as costs associated with recovering a number of systems across the Morgan Group.

It remains challenging to estimate precisely the extent of any impact on our H1 2023 trading. During January, a number of sites experienced a delay in restarting production and shipping due to the cyber security incident. Whilst demand has remained strong during January, we are experiencing production inefficiency during the recovery period which, based on current estimates, could lead to adjusted operating profit for FY2023 being approximately 10% to 15% below our previous expectations.

The Group has a strong balance sheet and does not expect the incident to have a material long term impact.

 ¹ Company compiled consensus for adjusted operating profit is £139.2m, with a range of £133.5m to £145.0m.

2022 Preliminary results timing

As a result of the systems impact from the cyber security incident, we are working with our auditors to reschedule the audit of the 2022 preliminary results and currently expect to be able to issue them by the end of April 2023.

Revised dates for our FY2022 preliminary results and our 2023 Annual General Meeting will be published in due course.

 

This announcement contains inside information. The person responsible for arranging the release of this announcement is Richard Armitage, CFO. The company's LEI is I4K14LL95N2PHDL7EG85.

 

For further enquiries:

Pete Raby, CEO Morgan Advanced Materials plc 01753 837000

Richard Armitage, CFO

Nina Coad Brunswick 0207 404 5959

 

All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific adjusting items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which the group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results, and the group's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCXQLLBXLLFBBQ
Date   Source Headline
22nd Aug 20132:33 pmRNSDirector/PDMR Shareholding
20th Aug 20132:51 pmRNSDirector/PDMR Shareholding
13th Aug 20135:35 pmRNSHolding(s) in Company
8th Aug 20134:14 pmRNSDirector/PDMR Shareholding
8th Aug 20139:35 amRNSHalf Yearly Report
5th Aug 20131:01 pmRNSDirector/PDMR Shareholding
30th Jul 201310:45 amRNSDirector/PDMR Shareholding
24th Jul 20137:00 amRNSHalf Year Results
27th Jun 201310:12 amRNSHolding(s) in Company
24th Jun 201310:36 amRNSBlocklisting Interim Review
7th Jun 20131:40 pmRNSDirector/PDMR Shareholding
5th Jun 20134:43 pmRNSDirector/PDMR Shareholding
4th Jun 201310:52 amRNSHolding(s) in Company
31st May 201310:40 amRNSTotal Voting Rights
31st May 201310:24 amRNSDirector/PDMR Shareholding
28th May 20135:19 pmRNSDirector/PDMR Shareholding
24th May 201312:18 pmRNSIssue of Equity
24th May 201310:12 amRNSNon Regulatory Announcement
22nd May 20134:25 pmRNSDirector/PDMR Shareholding
20th May 201311:39 amRNSDirector/PDMR Shareholding
17th May 201312:57 pmRNSDirector/PDMR Shareholding
10th May 20134:55 pmRNSResult of AGM
10th May 201310:00 amRNSAppointment of a Non-Executive Director
10th May 20137:00 amRNSInterim Management Statement
24th Apr 201312:09 pmRNSScrip Dividend Price
19th Apr 201311:20 amRNSDirector/PDMR Shareholding
10th Apr 201310:14 amRNSDirector/PDMR Shareholding
27th Mar 20135:38 pmRNSChange of Name
26th Mar 20134:25 pmRNSAnnual Financial Report
26th Mar 201311:44 amRNSDirector/PDMR Shareholding
14th Mar 20139:54 amRNSDirector/PDMR Shareholding
12th Mar 20131:50 pmRNSDirector/PDMR Shareholding
26th Feb 20133:55 pmRNSHolding(s) in Company
19th Feb 20131:09 pmRNSHolding(s) in Company
19th Feb 20131:08 pmRNSHolding(s) in Company
14th Feb 20137:05 amRNSChange of responsibilities of a director
14th Feb 20137:00 amRNSFull Year Results
5th Feb 20135:40 pmRNSHolding(s) in Company
31st Jan 201310:44 amRNSTotal Voting Rights
18th Jan 201312:38 pmRNSHolding(s) in Company
15th Jan 20132:07 pmRNSDirector/PDMR Shareholding
10th Jan 20139:54 amRNSTotal Voting Rights
3rd Jan 20133:47 pmRNSIssue of Equity
18th Dec 20124:54 pmRNSBlocklisting Interim Review
11th Dec 20129:35 amRNSDirector/PDMR Shareholding
6th Dec 20129:59 amRNSDirector/PDMR Shareholding
6th Dec 20129:55 amRNSDirector/PDMR Shareholding
29th Nov 20129:07 amRNSScrip Dividend Price
30th Oct 20125:08 pmRNSHolding(s) in Company
30th Oct 20129:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.